- Companies
- Edge Medical Robotics
Edge Medical Robotics Funding, Investors & Competitors
Edge Medical Robotics has raised $308M across 4 funding rounds, most recently a $200M Series C in November 2021.
Last Edge Medical Robotics funding round
$200M
Series C · Nov 2021
Cumulative funding Edge Medical Robotics raised
$308M
across 4 funding rounds
Key investors in Edge Medical Robotics
HSG
Temasek
Vertex Ventures China
Boyu Capital
LYFE Capital
3H Health Investment
Poly Real Estate
Lenovo Star
About Edge Medical Robotics
Edge Medical Robotics is a Shenzhen-headquartered developer of surgical robots founded on May 4, 2017, focusing on minimally invasive systems for orthopedic and general surgery procedures. The company produces robotic arms with 7 degrees of freedom, 3D visualization platforms, and haptic feedback interfaces certified under China's NMPA standards. Edge exports to Southeast Asia and Middle East markets emphasizing tremor filtration and precision targeting.
Founded
2017
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Edge Medical Robotics Funding History
Edge Medical Robotics has raised a total of $308M across 4 funding rounds.
Edge Medical Robotics' first fundraising round was a $400K Series A in January 2019. The most recent completed round was a $200M Series C in November 2021.
Edge Medical Robotics funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Nov 2021 | Series C | Boyu Capital (lead); HSG (lead); Temasek (lead) | $200M | Edge Medical Robotics, a China-based developer of surgical robotic arms for multi-port laparoscopic surgery, raised $200 million in a Series C round around November 4, 2021, co-led by Boyu Capital, Temasek, and Sequoia Capital China, with participation from OrbiMed, Octagon Capital, Sage Partners, Greater Bay Area Homeland Investments, Mirae Asset, Lyfe Capital, 3H Health Investment, and Guoce Capital. The company, previously backed by corporates including Legend Holdings, Kangji Medical, and Poly Group, plans to use the funds for business development and commercialization of its technology. This followed a Series B round in January 2021 of approximately $92.6 million co-led by Kangji Medical and Lyfe Capital, alongside 3H Health, Panorama Capital, Poly Capital, Vertex Ventures China, BioTrack Capital, and Alwin Capital; a pre-Series B of over $14.8 million in September 2020 from Legend Star, Poly Capital, 3H Health, and Guoce Capital; and an earlier Series A-plus led by Legend Star and Poly Capital. The company later achieved a HKD 23.2 billion market capitalization at its Hong Kong IPO in January 2026, listing 27,722,200 H shares at HKD 43.24 per share and raising approximately HKD 1.199 billion, with strong oversubscription and cornerstone investors including Tencent and OrbiMed. |
| Jan 2021 | Series B | LYFE Capital (lead); Vertex Ventures China | $93M | Edge Medical Robotics is a China-based advanced surgical robotics company founded in 2017 in Shenzhen, dedicated to designing, developing, and manufacturing surgical robots for minimally invasive and non-invasive surgery. The company specializes in multi-port laparoscopic, single-port endoscopic, and natural orifice surgical robotic systems, becoming the first in China and second globally to receive regulatory approvals across all three product categories. In January 2021, Edge Medical closed a Series B funding round at approximately $92.6 million co-led by Kangji Medical and Lyfe Capital, with participation from 3H Health Investment, Poly Group (via Poly Capital), Vertex Ventures China, BioTrack Capital, and Alwin Capital. The company had previously raised over $14.8 million in pre-Series B funding in September 2020 and an undisclosed Series A-plus round in August 2020 in the eight-figure yuan range. Edge Medical deployed Series B proceeds toward business development and technology commercialization, establishing itself as a key player in China's surgical robotics market. By January 2026, the company completed its initial public offering on the Hong Kong Stock Exchange under Chapter 18A biotech rules, with the listing expected to raise approximately HK$1.2 billion and opening at a market capitalization of HKD 23.2 billion, backed by cornerstone investors including Abu Dhabi Investment Authority, UBS, Tencent, and OrbiMed. |
| Sep 2020 | Series B | 3H Health Investment (lead); Guoce Group; Poly Real Estate; Lenovo Star | $15M | Edge Medical Robotics, a Shenzhen-based developer of surgical robotic arms for multi-port laparoscopic surgery, completed a pre-series B funding round in September 2020, raising over $14.8 million from Poly Capital, 3H Health Investment, Guoce Capital, and Legend Star (Lenovo Star). 3H Health Investment led the round. This followed a series A+ round five months earlier led by Legend Star and Poly Capital in the eight-figure yuan range. The company provides surgical equipment including robotic arms and had previously received undisclosed funding in 2019. |
| Jan 2019 | Series A | - | $400K | - |
Who has invested in Edge Medical Robotics?
9 investors have backed Edge Medical Robotics across its funding rounds, including HSG, Temasek, Vertex Ventures China, Boyu Capital, LYFE Capital and 3H Health Investment.
Lead investors include Boyu Capital, HSG, Temasek, LYFE Capital and 3H Health Investment.
Edge Medical Robotics Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Lead | Nov 2021 | ||
| 1 | Lead | Nov 2021 | ||
| 1 | Participant | Sep 2020 | ||
| 1 | Participant | Sep 2020 | ||
| -- | 1 | Participant | Sep 2020 | |
| 1 | Lead | Jan 2021 | ||
| 1 | Participant | Jan 2021 | ||
This data is available for Pro users. Sign up to see all 9 Edge Medical Robotics investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialEdge Medical Robotics Competitors
Edge Medical Robotics competitors include listed companies like Siemens, Johnson & Johnson, Roche and Thermo Fisher Scientific, and private ones like Biosplice Therapeutics and Neuralink.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $91B | $15B | $234B | 2.9x | ||
| Publicly listed | $94B | $40B | $651B | 6.8x | ||
| Publicly listed | $77B | $26B | $351B | 4.9x | ||
| Publicly listed | $45B | $11B | $243B | 6.0x | ||
| Private | - | - | $12B | - | ||
| Private | - | - | $9B | - |
Edge Medical Robotics Public Comps
Edge Medical Robotics is still privately-owned, but its public comps include Samsung, Johnson & Johnson, Roche, Thermo Fisher Scientific, Siemens, Schneider Electric, Abbott, ABB, Hitachi and Danaher.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $243B | $67B | 4.4x | 2.4x | 15.8x | 4.4x | |||
| $94B | $40B | 7.2x | 6.8x | 17.0x | 18.3x | |||
| $77B | $26B | 5.0x | 4.9x | 14.6x | 12.4x | |||
| $45B | $11B | 6.3x | 6.0x | 26.8x | 23.6x | |||
| $91B | $15B | 3.0x | 2.9x | 18.1x | 15.7x | |||
| $46B | $9.5B | 4.3x | 3.9x | 21.0x | 18.4x | |||
| $44B | $12B | 4.6x | 4.2x | 17.4x | 15.8x | |||
| $33B | $6.9B | 5.4x | 4.9x | 25.9x | 22.6x | |||
This data is available for Pro users. Sign up to see all Edge Medical Robotics competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Edge Medical Robotics
| When was Edge Medical Robotics founded? | Edge Medical Robotics was founded in 2017. |
| Where is Edge Medical Robotics headquartered? | Edge Medical Robotics is headquartered in Shenzhen, China. |
| Is Edge Medical Robotics publicly listed? | No, Edge Medical Robotics is a private, VC-backed company. |
| How much funding has Edge Medical Robotics raised? | Edge Medical Robotics has raised $308M across 4 funding rounds. |
| What was Edge Medical Robotics' last funding round? | Edge Medical Robotics' last funding round was a $200M Series C in November 2021, led by Boyu Capital, HSG and Temasek. |
| Who are Edge Medical Robotics' investors? | Edge Medical Robotics' investors include Temasek, Boyu Capital, Guoce Group, Poly Real Estate, Lenovo Star, LYFE Capital, Vertex Ventures China, 3H Health Investment and HSG. |
| Which companies are comparable to Edge Medical Robotics? | Companies comparable to Edge Medical Robotics include Siemens, Johnson & Johnson, Roche, Thermo Fisher Scientific, Biosplice Therapeutics and Neuralink. |
See companies similar to Edge Medical Robotics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




